Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | 77.65% | 99.73% | 78.52% | -10.89% | -13.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 77.65% | 99.73% | 78.52% | -10.89% | -13.28% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 77.65% | 99.73% | 78.52% | -10.89% | -13.28% |
| SG&A Expenses | -33.35% | -32.37% | -29.01% | -25.29% | -17.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -84.33% | -48.07% | -29.85% | -15.15% | -4.94% |
| Operating Income | 205.00% | 175.77% | 125.66% | 18.73% | -2.39% |
| Income Before Tax | 197.92% | 162.69% | 119.13% | 15.06% | -16.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 197.64% | 162.16% | 119.13% | 15.06% | -16.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 197.64% | 162.16% | 119.13% | 15.06% | -16.54% |
| EBIT | 205.00% | 175.77% | 125.66% | 18.73% | -2.39% |
| EBITDA | 206.38% | 177.27% | 126.78% | 18.69% | -2.56% |
| EPS Basic | 198.24% | 154.63% | 113.89% | 67.08% | 71.45% |
| Normalized Basic EPS | 217.39% | 169.24% | 122.76% | 70.75% | 75.89% |
| EPS Diluted | 197.71% | 154.53% | 113.89% | 67.07% | 71.45% |
| Normalized Diluted EPS | 217.37% | 169.22% | 122.76% | 70.75% | 75.89% |
| Average Basic Shares Outstanding | -0.12% | 7.42% | 37.95% | 93.45% | 226.37% |
| Average Diluted Shares Outstanding | -0.10% | 7.43% | 37.95% | 93.45% | 226.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |